VEEV trades 53.5% below Wall Street's consensus target of $235.38.
Last 12 months price action with 12-month analyst target path
The base valuation assumes VEEV achieves its forward estimates and maintains a stable P/E multiple of 16.9x. This scenario reflects the blended consensus of 43 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Veeva Systems Inc. (VEEV) has a Wall Street consensus price target of $235.38, based on estimates from 43 covering analysts. With the stock currently trading at $153.30, this represents a potential upside of +53.5%. The company has a market capitalization of $24.90B.
Analyst price targets range from a low of $165.00 to a high of $320.00, representing a 66% spread in expectations. The median target of $230.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 29 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, VEEV trades at a trailing P/E of 28.2x and forward P/E of 16.9x. The forward PEG ratio of 0.93 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +59.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $242.66, with bear and bull scenarios of $152.87 and $319.72 respectively. Model confidence stands at 60/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CRMSalesforce, Inc. | $124.3B | $151.78 | $265.75 | +75.1% | Buy | 12.9x | 97 |
DOCSDoximity, Inc. | $3.8B | $20.46 | $29.47 | +44.0% | Hold | 14.3x | 23 |
MEDPMedpace Holdings, Inc. | $13.1B | $460.20 | $498.86 | +8.4% | Hold | 27.1x | 19 |
HUBSHubSpot, Inc. | $9.0B | $176.03 | $285.14 | +62.0% | Buy | 13.4x | 47 |
DSGXThe Descartes Systems Group Inc. | $5.8B | $67.33 | $98.67 | +46.5% | Buy | 36.1x | 15 |
PCORProcore Technologies, Inc. | $6.0B | $39.99 | $67.40 | +68.5% | Buy | 23.8x | 24 |
PFEPfizer Inc. | $143.5B | $25.22 | $26.75 | +6.1% | Hold | 8.5x | 39 |
JNJJohnson & Johnson | $550.4B | $228.39 | $251.55 | +10.1% | Buy | 19.7x | 40 |
MRKMerck & Co., Inc. | $281.2B | $113.87 | $131.58 | +15.6% | Buy | 22.2x | 37 |
LLYEli Lilly and Company | $1.0T | $1098.13 | $1271.24 | +15.8% | Buy | 30.0x | 45 |
Quick answers to the most common questions about buying VEEV stock.
The consensus Wall Street price target for VEEV is $235.38, representing 53.5% upside from the current price of $153.3. With 43 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
VEEV has a consensus rating of "Buy" based on 43 Wall Street analysts. The rating breakdown is predominantly bullish, with 29 Buy/Strong Buy ratings. The consensus 12-month price target of $235.38 implies 53.5% upside from current levels.
With a forward P/E of 16.919x, VEEV trades at a relatively low valuation. The consensus target of $235.38 implies 53.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $320 for VEEV, while the most conservative target is $165. The consensus of $235.38 represents the median expectation. Our quantitative valuation model projects a bull case target of $320 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
VEEV is heavily covered by Wall Street, with 43 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 29 have Buy ratings, 13 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VEEV stock forecast based on 43 Wall Street analysts shows a consensus price target of $235.38, with estimates ranging from $165 (bear case) to $320 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $243, with bear/bull scenarios of $153/$320.
Our quantitative valuation model calculates VEEV's fair value at $243 (base case), with a bear case of $153 and bull case of $320. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 60/100.
VEEV trades at a forward P/E ratio of 16.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 28.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on VEEV, with a "Buy" consensus rating and $235.38 price target (53.5% upside). 29 of 43 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VEEV analyst price targets range from $165 to $320, a 66% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $235.38 consensus represents the middle ground. Our model's $153-$320 range provides an independent fundamental perspective.
Deep dive into VEEV consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.